Collagen-Derived α-Helical Peptides Show Antimicrobial Activity with Low Cytotoxicity

Bottom line: The human extracellular matrix contains hidden antimicrobial peptides within collagen that kill bacteria at low concentrations while sparing human cells — a potentially transformative finding for the antibiotic resistance crisis.

Antimicrobial peptides (AMPs) are short, typically cationic molecules produced by virtually all living organisms as part of innate immune defense. Most known AMPs come from dedicated immune genes, but a growing body of research suggests that larger structural proteins may harbor cryptic antimicrobial sequences that are released during tissue remodeling or injury.

Study Design

Published in ACS Infectious Diseases (PMID: 41528266), this study investigated whether collagen proteins — the most abundant structural proteins in the human body — contain latent α-helical AMPs within their nonfibrous extracellular matrix domains.¹

The team used a computational screening approach to identify candidate sequences with amphipathic α-helical propensity from collagen protein families. Top-ranked peptides were synthesized and tested against panels of Gram-positive and Gram-negative bacteria. Mechanism of action was assessed using lipid membrane disruption assays, and cytotoxicity was measured in human cell lines.

Key Findings

• Multiple active peptides identified: Several collagen-derived sequences demonstrated antimicrobial activity at minimum inhibitory concentrations (MICs) in the low micromolar range against clinically relevant pathogens.¹
• Membrane disruption confirmed: The peptides disrupted bacterial membrane-mimicking lipid vesicles in a dose-dependent manner, consistent with the canonical AMP mechanism of pore formation or membrane destabilization.¹
• Low cytotoxicity: Human cell viability remained above 90% at concentrations well above the MIC values, indicating a favorable selectivity index for bacterial over mammalian membranes.¹
• ML predictors underperformed: Interestingly, peptides ranked highly by machine-learning antimicrobial predictors showed reduced or no activity, while the structure-guided approach yielded the most potent candidates — highlighting limitations of current AI-based AMP prediction.¹

Clinical Context

With antimicrobial resistance projected to cause 10 million annual deaths by 2050, the need for novel antibiotic scaffolds is urgent. This study positions the extracellular matrix — previously considered purely structural — as a reservoir of immune-active peptides. The findings suggest that tissue injury may release collagen fragments that serve a dual purpose: structural remodeling and local infection defense.

Clinical implication: While these peptides are years from clinical application, the discovery validates collagen as a source of new AMP scaffolds and may guide the development of next-generation topical or wound-care antimicrobials derived from human proteins.

References

1. α-Helical Peptides Encoded in Collagen Exhibit Antimicrobial Activity and Low Cytotoxicity. ACS Infectious Diseases. 2026. PMID: 41528266